Dimensional Fund Advisors LP Has $35.30 Million Holdings in UiPath Inc. (NYSE:PATH)

Dimensional Fund Advisors LP increased its stake in shares of UiPath Inc. (NYSE:PATH) by 37.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,783,571 shares of the healthcare company’s stock after acquiring an additional 754,519 shares during the period. Dimensional Fund Advisors LP owned 0.49% of UiPath worth $35,296,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the stock. ORG Partners LLC grew its holdings in UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in UiPath in the 2nd quarter valued at approximately $28,000. Redwood Wealth Management Group LLC bought a new position in UiPath during the second quarter worth $43,000. GAMMA Investing LLC raised its position in shares of UiPath by 40.2% during the first quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after buying an additional 632 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. lifted its position in shares of UiPath by 122.5% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock worth $58,000 after acquiring an additional 1,407 shares during the period. 62.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on PATH shares. Barclays lifted their price target on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research report on Friday, September 6th. Wells Fargo & Company lifted their price objective on UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a report on Friday, September 6th. TD Cowen cut their target price on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, September 6th. Finally, Evercore ISI upped their price target on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, UiPath presently has a consensus rating of “Hold” and an average target price of $17.71.

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 22.37% of the stock is owned by corporate insiders.

UiPath Stock Performance

Shares of PATH opened at $12.40 on Wednesday. The firm has a market capitalization of $7.10 billion, a price-to-earnings ratio of -77.47 and a beta of 0.87. UiPath Inc. has a 52 week low of $10.37 and a 52 week high of $27.87. The business’s fifty day moving average price is $12.17 and its two-hundred day moving average price is $15.29.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same period in the prior year, the business posted ($0.09) earnings per share. UiPath’s revenue was up 10.0% compared to the same quarter last year. As a group, research analysts forecast that UiPath Inc. will post -0.23 EPS for the current year.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.